Duke CT Surgery Outcomes Group

Excited for #ISHLT2021 this weekend! Tune in on Wed April 28th from 11:45-11:50 EDT to hear our #MiniOral discussing use of 🫁 allografts w/ “extreme” ischemic times for txp @DukeCTOutcomes @DukeSurgery @DukeCTSurgery @mghartwigmd @SJKesseli @DanaeOlaso @brandi_bottiger

Thank you to @STS_CTsurgery for highlighting our study in this #STS2021 press briefing: 🔹Sex Disparities on Coronary Artery Bypass Grafting Techniques @DukeSurgery @DukeCTSurgery @DCRINews @DukeSurgRes @DukeCTOutcomes youtube.com/watch?v=avf4RL…

Just published in @SurgJournal: our @STS_CTsurgery analysis of Ravitch vs Nuss repair of pectus excavatum 🔹No difference peri-op complications after adjustment 🔹Generally a low vol procedure for CT surgeons @DukeCTSurgery @DukeSurgery @DCRINews surgjournal.com/article/S0039-…

Our post-hoc analysis of LEVO-CTS now published in @AmericanHeartJ 🔹No association between levosimendan and post-op AKI in low EF patients undergoing cardiac surgery @DCRINews @DukeSurgery @DukeCTSurgery @RenatoDLopes1 @DukeCTOutcomes @vigneshr11

Just published @Transpl_Int: Center volume and primary graft dysfunction after lung transplant 🔹Near linear association b/w ⬆️ center volume and ⬇️ likelihood of grade 3 PGD 🔹Improved survival after PGD with ⬆️ volume at low and medium volume centers onlinelibrary.wiley.com/doi/10.1111/tr…

Just published in @AATSJournals #JTCVS: Factors associated with short- versus long-term survival after lung transplant 🔹Minimal overlap between factors associated with 1- and 10-year survival 🔹Widely used LAS not associated with long-term survival sciencedirect.com/science/articl…

Just published @AmericanHeartJ: Post-hoc analysis of LEVO-CTS trial examining association between levosimendan and AKI in low EF cardiac surgery patients 🔹Levosimendan NOT associated with risk of AKI @DCRINews @DukeSurgery @DukeCTSurgery @DukeHeartCenter @Duke_Anesthesia

@maraantonoff @MDAndersonNews @UTH_CVSurgery @IanCBostock1 @TSRA_official @tssmn @ThoracicStudent @WomenInThoracic @MDAndersonLib @TECoG_ @soraya_voigtMD your life’s work

Tomorrow’s @MDAndersonNews - @UTH_CVSurgery debate style journal club, on the management of mesothelioma. Please join us and spread the word about this free educational event! @IanCBostock1 @TSRA_official @tssmn @ThoracicStudent Join here mdacc.zoom.us/webinar/regist…

Amazing work by @sehalpern5 and team! Paradigm-shifting work introducing a new way to evaluate the performance of OPOs - an integral aspect of the US transplant system #TransplantTwitter @DukeSurgery @DukeCTSurgery @DukeCTOutcomes @CRTP_DukeSOM @amjtransplant @tssmn

🔥Hot off the press🔥 We proposed a new 3-tier system for OPO performance evaluation in #LungTxp out now in @amjtransplant. Huge thanks & congrats to the whole team! @ojawitzMD @vigneshr11 @AshleyYJChoi @mghartwigmd @CMSGov @UNOSNews onlinelibrary.wiley.com/doi/abs/10.111…

Outstanding editorial comment by @ojawitzMD from @DukeSurgery @DukeCTSurgery @DCRINews on our Explant TAVR paper. 👇👇 onlinejacc.org/content/76/16/…

Great work @JulieDoberne and team! @annalsthorsurg @UNOSNews @DukeSurgery @WomenInThoracic

Online now @amjtransplant! Our lung transplant experience during the early #COVID19 pandemic. onlinelibrary.wiley.com/doi/abs/10.111… ✅pre-txp testing ✅risk factor screening ✅local procurements ⬆️txp volume @mghartwigmd @DanaeOlaso @DukeSurgery @DukeCTSurgery

Now in press at Perfusion, we describe an operation strategy (STAR perfusion) that could decrease ischemic time during complex Norwood procedures by over 2 fold. Excited to see this out, thanks to the guidance of @TurekPedHearts! @DukeCTOutcomes doi.org/10.1177/026765…

Excited to see our NCDB analysis on the impact of age of surgical outcomes for locally advanced esophageal cancer available online @annalsthorsurg annalsthoracicsurgery.org/article/S0003-… Thanks to @vigneshr11 @ojawitzMD @BTongMD and Drs D'Amico & Harpole for their work on this.

Thanks: @BTongMD @ojawitzMD @vigneshr11 @DukeSurgRes @DukeCTSurgery @ECUSurgery and Drs. Harpole and D'Amico

@krisrho93 will present a poster on disparities in guideline-concordant adjuvant chemo in node-positive esophageal cancer. @soraya_voigtMD's poster examines tumor size and adjuvant chemo in node-negative esophageal cancer.

Congratulations to @AJustinRucker2, @krisrho93, and @soraya_voigtMD on their abstracts accepted to @AATSHQ #ITSOS2020!

Check out our contribution in the new special #ERASCardiac issue of @CritCareClinics: 🔹How to start an #ERAS Cardiac program @JudsonBWilliams @danengelmanmd @DukeCTSurgery @DukeHeartCenter @DukeSurgery @DCRINews @WakeMed criticalcare.theclinics.com/article/S0749-…